Identification of an overabundant cholesterol precursor in hepatitis B virus replicating cells by untargeted lipid

Mary A Rodgers1, Alan Saghatelian, Priscilla L Yang

  • 1Department of Microbiology and Molecular Genetics, Harvard Medical School, 200 Longwood Avenue, Boston, Massachusetts 02115, USA.

Insights

Hepatitis B virus (HBV) infection selectively increases 7-dehydrocholesterol (7-DHC), a cholesterol precursor, in host cells. This finding suggests viruses may utilize specific sterols, opening new avenues for antiviral drug discovery.

Area of Science:

  • Virology
  • Metabolomics
  • Biochemistry

Background:

  • Viruses depend on host lipid metabolism for replication.
  • Host lipid pathways are emerging as targets for antiviral therapies.
  • The specific lipid metabolites viruses utilize remain largely unexamined.

Purpose of the Study:

  • To identify lipid metabolites altered by hepatitis B virus (HBV) replication.
  • To investigate the impact of viral infection on cellular lipid metabolism.
  • To explore potential novel antiviral targets.

Main Methods:

  • Untargeted metabolite profiling using liquid chromatography-mass spectrometry (LC-MS).
  • Identification of altered metabolites via mass spectrometry and standard coinjection.
  • Analysis of viral replication impact on host lipid profiles.

Main Results:

  • HBV replication significantly altered cellular lipid metabolism.
  • An ion identified as 7-dehydrocholesterol (7-DHC) was 18-fold overabundant in HBV-infected cells.
  • Major lipid classes remained unaffected, indicating selective metabolite utilization.

Conclusions:

  • HBV infection is associated with the selective accumulation of 7-DHC.
  • Viruses, like HBV, may preferentially utilize specific sterols over others.
  • Untargeted metabolomics is valuable for identifying critical viral metabolites and potential drug targets.